Calton & Associates’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,011
| Closed | -$142K | – | 213 |
|
|
2023
Q4 | $142K | Buy |
+10,011
| New | +$142K | 0.06% | 232 |
|
|
2023
Q3 | – | Sell |
-10,923
| Closed | -$137K | – | 163 |
|
|
2023
Q2 | $137K | Sell |
10,923
-441
| -4% | -$5.54K | 0.06% | 202 |
|
|
2023
Q1 | $126K | Sell |
11,364
-1,023
| -8% | -$11.3K | 0.06% | 223 |
|
|
2022
Q4 | $151K | Sell |
12,387
-40
| -0.3% | -$488 | 0.06% | 265 |
|
|
2022
Q3 | $129K | Sell |
12,427
-4,138
| -25% | -$43K | 0.07% | 199 |
|
|
2022
Q2 | $177K | Sell |
16,565
-955
| -5% | -$10.2K | 0.1% | 222 |
|
|
2022
Q1 | $165K | Buy |
+17,520
| New | +$165K | 0.05% | 334 |
|
|
2021
Q1 | – | Sell |
-9,178
| Closed | -$212K | – | 410 |
|
|
2020
Q4 | $212K | Sell |
9,178
-2,252
| -20% | -$52K | 0.04% | 353 |
|
|
2020
Q3 | $161K | Sell |
11,430
-1,193
| -9% | -$16.8K | 0.03% | 324 |
|
|
2020
Q2 | $190K | Sell |
12,623
-90
| -0.7% | -$1.36K | 0.04% | 310 |
|
|
2020
Q1 | $117K | Buy |
12,713
+1,656
| +15% | +$15.2K | 0.03% | 286 |
|
|
2019
Q4 | $108K | Buy |
11,057
+412
| +4% | +$4.02K | 0.02% | 350 |
|
|
2019
Q3 | $85K | Buy |
+10,645
| New | +$85K | 0.02% | 338 |
|